Abstract
Meeting Abstract: 2024 ASCO Annual Meeting
Background: Malignant superior vena cava syndrome (SVCS) is a clinical problem that results from the obstruction of blood flow in the superior vena cava by an underlying malignancy. It may be caused by external compression or internal obstruction due to a thrombus or direct invasion by tumor cells. Though lung malignancy is the most common cause of SVCS, there is a lack of data on in-hospital outcomes in these patients. Methods: We queried the National Inpatient Sample 2018-2020 to identify hospitalizations with lung cancer including both small cell and non small cell lung cancer. Hospitalizations with diagnosis of acute SVC thrombosis were determined by using ICD-10 codes.Demographics and mortality rates were compared between two groups using chi square for categorical variables and t test for continuous variables. Multivariate regression analysis was further performed to study the impact of SVC thrombosis on mortality, LOS and total hospitalization cost. Results: A total of 2011620 hospitalizations with lung cancer were identified. Of these, 2855 (0.0014%) had acute SVC thrombosis. These patients were younger with a mean age of 63 years. African-Americans and Hispanics were in a higher proportion in the cohort of hospitalizations with SVC thrombus as compared to those without. (Table 1). Multivariate regression analysis revealed higher odds of mortality (OR-1.94; C.I: 1.53-2.47; P < 0.001), LOS (OR 1.66; C.I:1.20- 2.31; P < 0.005) and total hospitalization cost (26211.15; C.I:22183.56- 30238.74; P < 0.001) in lung cancer hospitalizations. Conclusions: Our study shows that SVCT, has higher odds of mortality, length of stay and total hospital cost. Though the general recommendation is to continue anticoagulation, sometimes patients may require endovascular stent placement with/without thrombectomy. Though rare, SCVT can be life threatening and requires prompt attention.
Document Type
Meeting Abstract
Publication Date
5-2024
Publication Title
Journal of Clinical Oncology
Recommended Citation
Sanghvi, Ankushi; Nanavaty, Dhairya; Patel, Sagar; Vachhani, Bhavyakumar; Gaddam, Mrunanjali; Ginjupalli, Manasa; Jayakumar, Jayalekshmi; Adhikari, Nawaraj; Sinha, Rishav; Kumar, Vikash; Hotwani, Priya MD; and Nadeem, Ahmed, "In-hospital outcomes of patients with lung cancer with and without superior vena cava thrombosis: A nationwide analysis." (2024). Internal Medicine Residency. 11.
https://researchrepository.parkviewhealth.org/resident-im/11